Application YC di Cofactor Genomics
Cofactor Genomics ha partecipato a Y Combinator nel batch Summer 2015 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Summer 2015
- Settore
- HealthcareDiagnostics
- Dimensione team
- 13
- Stato
- Active
- Lanciata
- 2015
Founder
Dave MessinaFounder/COO
Jarret GlasscockFounder/CTO
Cosa fa Cofactor Genomics
Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).
Application YC di Cofactor Genomics, ricostruita
Domanda per Y Combinator
Cofactor Genomics, batch Summer 2015. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Cofactor Genomics
Cofactor closes the precision medicine gap with predictive diagnostics
We build diagnostic tests using RNA sequencing and predictive immune modeling to create biomarkers that better predict patient responses, mainly for cancer immunotherapy. Our product helps doctors select which patients will respond to specific treatments, improving outcomes where current diagnostics fall short.
We live and work in St. Louis, Missouri, and the company remains based there.
St. Louis grounds us with access to strong genomics talent and a supportive healthcare ecosystem, including relationships with national healthcare systems. We don't see a need to relocate right now.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Cofactor Genomics?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Cofactor Genomics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Cofactor Genomics si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Cofactor Genomics?
Cofactor Genomics apparteneva al batch Summer 2015 di Y Combinator.
Chi ha fondato Cofactor Genomics?
Cofactor Genomics è stato fondato da Dave Messina, Jarret Glasscock.
Cosa fa Cofactor Genomics?
Cofactor closes the precision medicine gap with predictive diagnostics
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Cofactor Genomics, e di ogni altro batch YC, è in YC Insights.
Più startup YC come Cofactor Genomics
